Gaurav Shah - Aug 17, 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Stock symbol
RCKT
Transactions as of
Aug 17, 2023
Transactions value $
-$73,750
Form type
4
Date filed
8/21/2023, 05:05 PM
Previous filing
Aug 15, 2023
Next filing
Nov 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$73.8K -4.77K -0.9% $15.47 525K Aug 17, 2023 Direct F1
holding RCKT Common Stock 208K Aug 17, 2023 By Spouse
holding RCKT Common Stock 198K Aug 17, 2023 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.